Wenzhan Yang

1.2k total citations
17 papers, 463 citations indexed

About

Wenzhan Yang is a scholar working on Pharmaceutical Science, Spectroscopy and Organic Chemistry. According to data from OpenAlex, Wenzhan Yang has authored 17 papers receiving a total of 463 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmaceutical Science, 5 papers in Spectroscopy and 4 papers in Organic Chemistry. Recurrent topics in Wenzhan Yang's work include Advanced Drug Delivery Systems (5 papers), Analytical Chemistry and Chromatography (4 papers) and Drug Solubulity and Delivery Systems (4 papers). Wenzhan Yang is often cited by papers focused on Advanced Drug Delivery Systems (5 papers), Analytical Chemistry and Chromatography (4 papers) and Drug Solubulity and Delivery Systems (4 papers). Wenzhan Yang collaborates with scholars based in United States, Singapore and Germany. Wenzhan Yang's co-authors include Melgardt M. de Villiers, Wilna Liebenberg, Daniel P. Otto, Suzanne Skolnik, Jan L. du Preez, Darren L. Reid, Margaret S. Landis, Phenil J. Patel, Manuel Sánchez-Félix and Venkata R. Krishnamurthy and has published in prestigious journals such as Cancer Research, Pharmaceutical Research and Journal of Pharmaceutical Sciences.

In The Last Decade

Wenzhan Yang

17 papers receiving 451 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenzhan Yang United States 10 207 142 135 88 68 17 463
Usha Yerramilli United States 8 166 0.8× 57 0.4× 107 0.8× 40 0.5× 70 1.0× 10 364
Karol Krzymiński Poland 14 282 1.4× 91 0.6× 163 1.2× 154 1.8× 17 0.3× 69 587
Sadafara A. Pillai India 16 420 2.0× 79 0.6× 75 0.6× 60 0.7× 64 0.9× 37 556
Ganesan Kumaravel India 10 365 1.8× 139 1.0× 169 1.3× 114 1.3× 105 1.5× 12 675
Konstantinos Skobridis Greece 17 347 1.7× 154 1.1× 230 1.7× 200 2.3× 41 0.6× 50 824
Maria Annunziata M. Capozzi Italy 21 898 4.3× 158 1.1× 186 1.4× 119 1.4× 27 0.4× 63 1.2k
Saeed R. Khan United States 11 61 0.3× 45 0.3× 109 0.8× 120 1.4× 46 0.7× 16 397
David Delmarre France 7 134 0.6× 66 0.5× 112 0.8× 175 2.0× 177 2.6× 8 539
Bernd Riebesehl Switzerland 8 59 0.3× 96 0.7× 127 0.9× 47 0.5× 122 1.8× 8 402
Fortuna Ponte Italy 15 237 1.1× 45 0.3× 122 0.9× 194 2.2× 22 0.3× 41 530

Countries citing papers authored by Wenzhan Yang

Since Specialization
Citations

This map shows the geographic impact of Wenzhan Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenzhan Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenzhan Yang more than expected).

Fields of papers citing papers by Wenzhan Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenzhan Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenzhan Yang. The network helps show where Wenzhan Yang may publish in the future.

Co-authorship network of co-authors of Wenzhan Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Wenzhan Yang. A scholar is included among the top collaborators of Wenzhan Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenzhan Yang. Wenzhan Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
3.
Yang, Wenzhan, et al.. (2023). Early evaluation of opportunities in oral delivery of PROTACs to overcome their molecular challenges. Drug Discovery Today. 29(2). 103865–103865. 11 indexed citations
4.
Yang, Wenzhan, Steve Cook, & Dedong Wu. (2023). Pre-clinical Formulation Development of an in situ Meglumine Salt of AZD5991: A Novel Macrocyclic Mcl-1 Inhibitor. Pharmaceutical Research. 40(4). 977–988. 1 indexed citations
5.
Yang, Wenzhan, et al.. (2022). Discovery solubility measurement and assessment of small molecules with drug development in mind. Drug Discovery Today. 27(5). 1315–1325. 46 indexed citations
6.
Sharma, Divya, et al.. (2021). Experimental design, development and evaluation of extended release subcutaneous thermo-responsive in situ gels for small molecules in drug discovery. Pharmaceutical Development and Technology. 26(10). 1079–1089. 5 indexed citations
7.
Yang, Wenzhan, Shobha Bhattachar, Phenil J. Patel, et al.. (2020). Modulating target engagement of small molecules via drug delivery: approaches and applications in drug discovery and development. Drug Discovery Today. 26(3). 713–723. 5 indexed citations
8.
Yang, Wenzhan, et al.. (2020). Application and Impact of Human Dose Projection from Discovery to Early Drug Development. AAPS PharmSciTech. 21(2). 44–44. 1 indexed citations
9.
Yang, Wenzhan, Venkata R. Krishnamurthy, Margaret S. Landis, et al.. (2020). The Evolving Druggability and Developability Space: Chemically Modified New Modalities and Emerging Small Molecules. The AAPS Journal. 22(2). 21–21. 40 indexed citations
10.
Hird, Alexander W., J. Paul Secrist, Ammar Adam, et al.. (2017). Abstract DDT01-02: AZD5991: A potent and selective macrocyclic inhibitor of Mcl-1 for treatment of hematologic cancers. Cancer Research. 77(13_Supplement). DDT01–2. 15 indexed citations
11.
Yang, Wenzhan, et al.. (2008). Effect of para-Sulfonato-Calix[n]arenes on the Solubility, Chemical Stability, and Bioavailability of a Water Insoluble Drug Nifedipine. Current Drug Discovery Technologies. 5(2). 129–139. 38 indexed citations
12.
Yang, Li, et al.. (2008). Entrapment of recombinant staphylokinase by liposomes: formulations, preparation, characterization and behavior in vivo. Journal of Drug Delivery Science and Technology. 18(4). 245–251. 2 indexed citations
13.
Yang, Wenzhan & Melgardt M. de Villiers. (2005). Effect of 4-sulphonato-calix[n]arenes and cyclodextrins on the solubilization of niclosamide, a poorly water soluble anthelmintic. The AAPS Journal. 7(1). E241–E248. 84 indexed citations
14.
Yang, Wenzhan, et al.. (2005). Physicochemical Characterization of Hydrated 4-Sulphonato-Calix[n]arenes: Thermal, Structural, and Sorption Properties. Supramolecular chemistry. 17(6). 485–496. 14 indexed citations
15.
Yang, Wenzhan & Melgardt M. de Villiers. (2004). The solubilization of the poorly water soluble drug nifedipine by water soluble 4-sulphonic calix[n]arenes. European Journal of Pharmaceutics and Biopharmaceutics. 58(3). 629–636. 97 indexed citations
16.
Liebenberg, Wilna, et al.. (2004). Improving the aqueous solubility of triclosan by solubilization, complexation, and in situ salt formation.. PubMed. 54(6). 537–50. 29 indexed citations
17.
Yang, Wenzhan & Melgardt M. de Villiers. (2004). Aqueous solubilization of furosemide by supramolecular complexation with 4-sulphonic calix[n]arenes. Journal of Pharmacy and Pharmacology. 56(6). 703–708. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026